Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02128906
Title Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

larynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Cetuximab + Docetaxel

Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.